Remove Biotechnology Remove Finance Remove Venture Capitalist
article thumbnail

Taxpayers Helped Apple, but Apple Won't Help Them

Harvard Business Review

It also received its early stage finance from the U.S. Venture capitalists entered only after government funding had gotten the company to the critical proof of concept. It is not by accident that the National Institutes of Health spends $31 billion a year on supporting innovation in biotechnology and pharmacology.

article thumbnail

A Quiet Revolution in Clean-Energy Finance

Harvard Business Review

Many venture capitalists are limiting their investments to the "demand-side" — aimed at reducing energy use — rather than investing in startups trying to change the way we produce energy. Their behavior displays promising parallels to the early days of the biotechnology industry.

Energy 14